In this edition, Incidental respiratory findings on low-dose CT lung cancer screening common; lack of guideline-concordant treatment for early-stage non-small cell lung cancer common; women at greater risk for more severe adverse events from cancer treatments, and more.
Read the full coverage here:
Incidental respiratory findings on low-dose CT lung cancer screening common
Lack of guideline-concordant treatment for early-stage non-small cell lung cancer common
Women at greater risk for more severe adverse events from cancer treatments
Visual, quantitative CT emphysema assessments linked to higher odds of lung cancer
Acetaminophen may reduce immunotherapy efficacy in patients with cancer
References:
Bessede A, et al. Abstract LBA12000. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
Kehl KL, et al. JAMA Oncol. 2022;doi: 10.1001/jamaoncol.2022.0039.
Pinsky PF, et al. Chest. 2022;doi:10.1016/j.chest.2021.11.015.
Unger JM, et al. J Clin Oncol. 2022;doi:10.1200/JCO.21.02377.
